QualityStocksNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Unveils Psychedelic Facilitator Training Program Based on Groundbreaking Psychotherapy Approach
Cybin (NYSE American: CYBN) (NEO: CYBN), a biotechnology company focused on progressing psychedelic therapeutics, is launching its own psychedelic facilitator training program. Called EMBARK, the project is led by expert faculty and provides psychedelic clinical trial facilitators with fundamental training to provide skillful, ethical care to individuals receiving psychedelic treatment. EMBARK emphasizes experiential learning and includes an in-person training retreat at the Whidbey Institute, a home for transformational learning in Washington state as well the training and practice sessions on the EMBARK model, a groundbreaking psychotherapy approach that incorporates psychedelic medicine with leading clinical approaches designed to promote supportive healing.…